Published

Should we be leery of being Leary? Concerns about psychedelic use by psychedelic researchers.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Journal of psychopharmacology (Oxford, England)
Date: 2023-01-01
Source: PubMed
DOI: 10.1177/02698811221133461
PubMed: 36377548

Authors

Kious B Schwartz Z Lewis B

Watch author

Derived topics and classifications

psilocybin PTSD Clinical Trial Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Australia Legalizes Psychedelics for Use in Depression, PTSD TherapyPsychiatric News · 2023-08-15 Should addiction researchers be interested in psychedelic science?Drug and Alcohol Review · 2017-04-10 Psychedelic-Assisted Therapy (Pat): A New Frontier in Mental Health TreatmentThe journal of desk research review and analysis. · 2025-12-16 Psychedelics and mental health: reimagining care through science, insight, and compassion.Frontiers in pharmacology · 2025-01-01 Ethical considerations for psychedelic-assisted therapy in military clinical settings.Journal of medical ethics · 2024-03-20 Ethical Complexities and Best Practices in Informed Consent Processes for Psilocybin Services: A Qualitative StudyNeuroethics · 2026-08-01 Is the Requirement for First-Person Experience of Psychedelic Drugs a Justified Component of a Psychedelic Therapist's Training?Cambridge quarterly of healthcare ethics: CQ: the international journal of healthcare ethics committees · 2023-03-02 Psychedelic Treatment with Psilocybin: Addressing Medical Malpractice Risk and Physicians' Concerns.The Journal of law, medicine & ethics: a journal of the American Society of Law, Medicine & Ethics · 2025-07-31